Correlation Between Suzhou Novoprotein and Innovative Medical

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Innovative Medical Management, you can compare the effects of market volatilities on Suzhou Novoprotein and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Innovative Medical.

Diversification Opportunities for Suzhou Novoprotein and Innovative Medical

0.52

Correlation Coefficient

Suzhou Novoprotein  Innovative Medical

Very weak diversification

The 3 months correlation between Suzhou and Innovative is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Innovative Medical go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Innovative Medical

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Innovative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 1.4 times less risky than Innovative Medical. The stock trades about -0.05 of its potential returns per unit of risk. The Innovative Medical Management is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  703.00  in Innovative Medical Management on December 2, 2024 and sell it today you would earn a total of  233.00  from holding Innovative Medical Management or generate 33.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Innovative Medical Management

Suzhou Novoprotein

Risk-Adjusted Performance

Very Weak

Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Innovative Medical

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Suzhou Novoprotein and Innovative Medical

The main advantage of trading using opposite Suzhou Novoprotein and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.

The idea behind Suzhou Novoprotein Scientific and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.